Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

1.1K
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
1.1K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

866
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
866
Altered States of Awareness01:06

Altered States of Awareness

1.6K
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

The benefits of timely access to treatment: Substance use disorders, healthcare utilization and employment.

Journal of health economics·2026
Same author

Development of the Occupational Therapy Health Routines Screening Tool: A Participatory Study.

OTJR : occupation, participation and health·2026
Same author

The Role of Self-Reported Willingness to Use Drugs in Public Health Research: Population-Level Projections of Adolescents' Decriminalised Cannabis Use and Associated Risk Profiles.

Drug and alcohol review·2025
Same author

MoveLab<sup>®</sup>: Validation and Development of Novel Cross-Platform Gait and Mobility Assessments Using Gold Standard Motion Capture and Clinical Standard Assessment.

Sensors (Basel, Switzerland)·2025
Same author

The COVID-19 global pandemic and allostatic load among a cohort of Black and Latina transgender women living with HIV.

Psychology of sexual orientation and gender diversity·2025
Same author

Non-Prescribed Use of Opioid Agonist Medications and Associations with Non-Fatal Overdoses: A Repeated Cross-Sectional Study across a Decade of Reduced Monitoring.

European addiction research·2025

Related Experiment Video

Updated: May 1, 2026

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K

Does liberalizing cannabis laws increase cannabis use?

Jenny Williams1, Anne Line Bretteville-Jensen2

  • 1Department of Economics, University of Melbourne, Australia.

Journal of Health Economics
|April 15, 2014
PubMed
Summary
This summary is machine-generated.

Decriminalizing cannabis laws significantly increases cannabis initiation, particularly among minors, within five years of policy change. This study analyzes policy timing and uses advanced models to reveal these effects.

Keywords:
Cannabis initiationDecriminalizationHazard rateNatural experiment

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.4K
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

922

Related Experiment Videos

Last Updated: May 1, 2026

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.4K
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

922

Area of Science:

  • Public Health
  • Criminology
  • Health Policy

Background:

  • The legal status of cannabis is a contentious policy issue.
  • Understanding the effects of cannabis law liberalization on use is crucial.

Purpose of the Study:

  • To investigate the impact of cannabis decriminalization on initiating cannabis use.
  • To examine the dynamics and heterogeneity of cannabis uptake following policy reform.

Main Methods:

  • Utilized a difference-in-difference approach combined with a discrete time duration model.
  • Exploited variations in the timing of cannabis policy reforms for identification.

Main Results:

  • Cannabis decriminalization leads to increased cannabis initiation.
  • The effect of decriminalization on cannabis uptake is concentrated among minors.
  • Increased uptake among minors is evident within the first five years post-decriminalization.

Conclusions:

  • Cannabis decriminalization is associated with a rise in cannabis use initiation.
  • Adolescent populations show a heightened response in cannabis uptake following decriminalization.